Serum neurofilament light chains in MS: Association with the Timed Up and Go

Allali, Gilles; Kuhle, Jens; Breville, Gautier; Leppert, David; Armand, Stéphane; Lalive d'Epinay, Patrice

doi:10.1212/NXI.0000000000000895

Scientific article

English

Serum neurofilament light chains in MS: Association with the Timed Up and Go

ContributorsAllali, Gilles; Kuhle, Jens; Breville, Gautier; Leppert, David; Armand, Stéphane

; Lalive d'Epinay, Patrice

Published inNeurology Neuroimmunology & Neuroinflammation, vol. 7, no. 6, e895

Publication date2020

Abstract

This cross-sectional study aims to assess the association between neuroaxonal damage assessed by serum neurofilament light chain (sNfL) and the Timed Up and Go (TUG)—a reliable and rapid measure of global neurologic disability—in patients with MS.

Affiliation entities

Research groups

Funding

Autre - Geneva University Hospitals (PRD 18-2016-II), the Swiss Multiple Sclerosis Society, and the Fondation Privée des HUG
Swiss National Science Foundation - Functional characterization of c-Met-expressing T cells in experimental immunology [176078]

Citation (ISO format)

ALLALI, Gilles et al. Serum neurofilament light chains in MS: Association with the Timed Up and Go. In: Neurology Neuroimmunology & Neuroinflammation, 2020, vol. 7, n° 6, p. e895. doi: 10.1212/NXI.0000000000000895

Article (Published version)

CC BY-NC-ND

Identifiers

PID : unige:151521
DOI : 10.1212/NXI.0000000000000895
PMID : 32978292

Additional URL for this publicationhttp://nn.neurology.org/lookup/doi/10.1212/NXI.0000000000000895

Journal ISSN2332-7812

244views

69downloads

Creation19/02/2021 11:31:00

First validation19/02/2021 11:31:00

Update17/01/2025 16:11:02

Status update17/01/2025 16:11:02

Last indexation17/01/2025 16:20:47

Archive ouverte UNIGE

Serum neurofilament light chains in MS: Association with the Timed Up and Go

This cross-sectional study aims to assess the association between neuroaxonal damage assessed by serum neurofilament light chain (sNfL) and the Timed Up and Go (TUG)—a reliable and rapid measure of global neurologic disability—in patients with MS.

Technical informations